Andrew is Professor of Pharmacology at the University of Prince Edward Island and holds the Jeanne and J. Louis Levesque Research Professorship in Nutrisciences and Health. He also holds an Honourary Professorship in Neuropharmacology at Aarhus University in Denmark and is a Fellow of the Canadian Academy of Health Sciences. His research interests are in the development of clinically-relevant animal models of neurological disease and understanding the molecular basis of presymptomatic neurological dysfunction.
Denis is a graduate of Dalhousie (B.Sc. and M.Sc.) and McGill (Ph.D.) Universities. He has more than 20 years experience in the development and characterization of small animal models of human diseases, and has played an integral role in the design and implementation of CNS|CRO’s research and development program. He is also inventor on two of the Company’s families of patents pending.
A founder of Neurodyn Inc. Chris Shaw is an acknowledged expert on animal models of neurological disease, especially ALS-Parkinsonian dementia complex. He is a professor of Ophthalmology in the Medical Faculty at UBC where he holds cross appointments to the Department of Physiology and Experimental Medicine, in addition to authoring over 100 peer reviewed publications and over 130 scientific abstracts. Chris has also edited or authored 4 books on topics in neuroscience.
Dr. Robertson is a Fellow of the Royal Society of Canada and is co-founder of the Brain Repair Center (BRC) at Dalhousie University. As a world recognized expert in Parkinson’s disease he serves on the peer review committee of the Parkinson Society of Canada and has been instrumental in the establishment of several clinical trials for treatment of Parkinson’s. He is Professor Emeritus of Pharmacology with the Faculty of Medicine at Dalhousie University, and also holds an appointment as adjunct professor at the University of Prince Edward Island.